PharmaWatch: Updates Impacting the Workers’ Compensation Industry

Pharmacist looks at and holds small box in left hand

Timely clinical updates and thought leadership on new drug and indication approvals, discontinuation and withdrawals, new dosages or formulations of existing products and generics introduced to the market. For questions regarding new updates, please email

News and Updates

FDA Approves Wegovy for Prevention of Major Cardiovascular Disease in Obese or Overweight Adults
On Friday, March 8, 2024, the FDA approved Wegovy (semaglutide) for a new indication--reduction of risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease who are obese or overweight. Wegovy should be used along with increased physical activity and a reduced calorie diet.

Learn more